Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats

Journal of Hypertension

Volumn 21, Issue 1, 2003, Pages 115-123

  Millette, Esther ^a   De Champlain, Jacques ^a   Lamontagne, Daniel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiotensin II; Coronary arteries; Deoxycorticosterone acetate; Endothelin; Hypertension; Vasoconstriction; Vasopressin

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 [2 (3,4 DIMETHOXYPHENYL)ETHOXY] 2 (4,6 DIMETHOXY 2 PYRIMIDINYLOXY) 3,3 DIPHENYLPROPIONIC ACID; 3 [2 (3,4 DIMETHOXYPHENYL)ETHOXY] 2 (4,6 DIMETHYLPYRIMIDIN 2 YLOXY) 3,3 DIPHENYLPROPIONIC ACID; ANGIOGENIN; CALCIUM CHANNEL L TYPE; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN; ENDOTHELIN A RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR AGONIST; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; PHORBOL 13 ACETATE 12 MYRISTATE; PROPIONIC ACID DERIVATIVE; PROTEIN KINASE C; SODIUM CHLORIDE; THROMBOXANE; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HEART FUNCTION; HEART RATE; HYPERTENSION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SIGNAL TRANSDUCTION;

EID: 12244252216     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200301000-00021     Document Type: Article

References (37)

1. Goodwin AT, Amrani M, Gray CC, Jayakumar J, Yacoub MH. Role of endogenous endothelin in the regulation of basal coronary tone in the rat. J Physiol (Lond) 1998; 511:549-557.
2. Lüscher TF, Oemar BS, Boulanger CM, Hahn AW. Molecular and cellular biology of endothelin and its receptors-Part I. J Hypertens 1993; 11:7-11.
3. Moreau P, d'Uscio LV, Shaw S, Takase H, Barton M, Lüscher TF. Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist. Circulation 1997; 96:1593-1597.
4. d'Uscio LV, Moreau P, Shaw S, Takase H, Barton M, Lüscher TF. Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. Hypertension 1997; 29:435-441.
5. Ammarguellat F, Larouche II, Schiffrin EL. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism. Circulation 2001; 103:319-324.
6. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999; 402:884-888.
7. Ikeo S, Yamauchi K, Shigematsu S, Nakajima K, Aizawa T, Hashizume K. Differential effects of growth hormone and insulin-like growth factor I on human endothelial cell migration. Am J Physiol Cell Physiol 2001; 280:C1255-C1261.
8. Yang ZH, Richard V, Segesser L von, Bauer E, Stulz P, Turina M, et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 1990; 82:188-195.
9. Larivière R, Deng LY, Day R, Sventek P, Thibault G, Schiffrin EL. Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat. J Mol Cell Cardiol 1995; 27:2123-2131.
10. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993; 21:294-300.
11. Matsumura Y, Kita S, Okui T. Mechanisms of endothelin-1-induced potentiation of noradrenaline response in rat mesenteric artery. Clin Exp Pharm Physiol 2001; 28:540-544.
12. Léan A De, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 2001; 235:E97-E102.
13. Karam H, Heudes D, Hess P, Gonzales MF, Loffler BM, Clozel M, et al. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovasc Res 1996; 31:287-295.
14. Brunner F. Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and in ischaemia and reperfusion. J Mol Cell Cardiol 1995; 27:1953-1963.
15. Millette E, Champlain J de, Lamontagne D. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension. J Hypertens 2000; 18:1783-1793.
16. Kubo T, Ibusuki T, Saito E, Kambe T, Hagiwara Y. Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats. Eur J Pharm 2000; 400:231-237.
17. Sirous ZN, Fleming JB, Khalil RA. Endothelin-1 enhances eicosanoidsinduced coronary smooth muscle contraction by activating specific protein kinase C isoforms. Hypertension 2001; 37:497-504.
18. Balwierczak JL. Two subtypes of the endothelin receptor (ETA and ETB) mediate vasoconstriction in the perfused rat heart. J Cardiovasc Pharm 1993; 22 (suppl. 8):S248-S251.
19. Wang QD, Li XS, Pernow J. Characterization of endothelin-1-induced vascular effects in the rat heart by using endothelin receptor antagonists. Eur J Pharm 1994; 271:25-30.
20. Amberg W, Hergenroder S, Hillen H, Jansen R, Kettschau G, Kling A, et al. Discovery and synthesis of (S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2-(4,6-dimethylpyrimidin-2-yloxy)-3, 3-diphenylpropionic acid (LU 302872), a novel orally active mixed ET(A)/ET(B) receptor antagonist. J Med Chem 1999; 42:3026-3032.
21. Doherty AM, Cody WL, He JX, DePue PL, Cheng XM, Welch KM, et al. In vitro and in vivo studies with a series of hexapeptide endothelin antagonists. J Cardiovasc Pharm 1993; 22 (suppl. 8):S98-S102.
22. Fluckiger JP, Nguyen PV, Li G, Yang XP, Schiffrin EL. Calcium, phosphoinositide, and 1,2-diacylglycerol responses of blood vessels of deoxycorticosterone acetate-salt hypertensive rats to endothelin-1. Hypertension 1992; 19:743-748.
23. Nguyen PV, Parent A, Deng LY, Fluckiger JP, Thibault G, Schiffrin EL. Endothelin vascular receptors and responses in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1992; 19:1198-11104.
24. Deng LY, Schiffrin EL. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol 1992; 262:H1782-H1787.
25. Larivière R, Sventek P, Thibault G, Schiffrin EL. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan. Can J Physiol Pharm 1995; 73:390-398.
26. Schiffrin EL, Larivière R, Li JS, Sventek P. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res 1996; 33:235-248.
27. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension 1994; 24:183-188.
28. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium- derived nitric oxide. J Clin Invest 1990; 85:587-590.
29. Wang QD, Gonon A, Shimizu M, Sjoquist PO, Pernow J. Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition. Acta Physiol Scand 1998; 163:325-330.
30. Neubauer S, Ertl G, Haas U, Pulzer F, Kochsiek K. Effects of endothelin-1 in isolated perfused rat heart. J Cardiovasc Pharm 1990; 16:1-8.
31. Karaki H, Sudjarwo SA, Hori M, Sakata K, Urade Y, Takai M, et al. ETB receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation. Eur J Pharm 1993; 231:371-374.
32. Warner TD, Mitchell JA, Nucci G de, Vane JR. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharm 1989; 13 (suppl. 5):S85-S88.
33. Taddei S, Vanhoutte PM. Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension 1993; 21:9-15.
34. Zaugg CE, Hornstein PS, Zhu P, Simper D, Lüscher TF, Allegrini PR, et al. Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts. Circulation 1996; 94:742-747.
35. Ergul S, Ergul A, Hudson JA, Puett D, Wieman BM, Durham MD, et al. The effect of regulation of high blood pressure on plasma endothelin-1 levels in blacks with hypertension. Am J Hypertens 1998; 11:1381-1385.
36. Rossi GP, Colonna S, Pavan E, Albertin G. Della RF, Gerosa G et al. Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo. Circulation 1999; 99:1147-1155.
37. Toyo-oka T. Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 1991; 83:476-483.